Atrovent®

ipratropium bromide

About Atrovent®

Prevention and treatment of shortness of breath in patients with chronic obstructive pulmonary disease (COPD) and mild to moderate bronchial asthma in adulthood and childhood as a supplement to beta-agonists in cases of acute asthma.


 

 

Professional Area

You are a Healthcare Professional or Journalists & Media Professional? Click below to be able to see and access respective content.

Product Key Facts

Indications

Chronic obstructive pulmonary disease (COPD) Chronic bronchitis Bronchial asthma

Brand Names

Atrovent®

Active ingredients

ipratropium bromide